AGP Picks
View all

The Persian Gulf Newswire
Provided by AGP

The Persian Gulf Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Persian Gulf Newswire.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 26, 2026

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Oct. 26, 2026

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Critical Metals Corp. Acquisition of European Lithium Approved by Supreme Court of Western Australia
Oct. 26, 2026

Critical Metals Corp. Acquisition of European Lithium Approved by Supreme Court of Western Australia

Indeterminate GlobeNewswire
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
Oct. 26, 2026

Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage

Indeterminate GlobeNewswire
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Oct. 26, 2026

Seismic Therapeutic to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature
Oct. 26, 2026

Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature

Indeterminate GlobeNewswire
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Oct. 26, 2026

Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline

Indeterminate GlobeNewswire
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
Oct. 26, 2026

Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer

Indeterminate GlobeNewswire
NevGold Appoints Sean Waller to Board of Directors; Key Addition of Project Development and Mineral Process Engineering Expertise
Oct. 26, 2026

NevGold Appoints Sean Waller to Board of Directors; Key Addition of Project Development and Mineral Process Engineering Expertise

Indeterminate GlobeNewswire
HI-VIEW IP SURVEY IDENTIFIES MULTIPLE POTENTIAL PORPHYRY TARGETS AT THE BLACK PEARL, TOODOGGONE REGION, BRITISH COLUMBIA
Oct. 26, 2026

HI-VIEW IP SURVEY IDENTIFIES MULTIPLE POTENTIAL PORPHYRY TARGETS AT THE BLACK PEARL, TOODOGGONE REGION, BRITISH COLUMBIA

Indeterminate GlobeNewswire
Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project
Oct. 26, 2026

Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project

Indeterminate GlobeNewswire
All NIOB Bardy Holes Hit Meaningful TREO Grades in at Least One Interval
Oct. 26, 2026

All NIOB Bardy Holes Hit Meaningful TREO Grades in at Least One Interval

Indeterminate GlobeNewswire
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
Oct. 26, 2026

BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives

Indeterminate GlobeNewswire
MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
Oct. 26, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Indeterminate GlobeNewswire
Nayax to Report 2026 Q3 Earnings on November 11, 2026
Oct. 26, 2026

Nayax to Report 2026 Q3 Earnings on November 11, 2026

Indeterminate GlobeNewswire
VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy
Oct. 26, 2026

VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
Oct. 26, 2026

Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Goldera Identifies Large Gold-Tungsten-Antimony Anomaly at Riley Brook, with Multiple Targets Remaining Open
Oct. 26, 2026

Goldera Identifies Large Gold-Tungsten-Antimony Anomaly at Riley Brook, with Multiple Targets Remaining Open

Indeterminate GlobeNewswire
BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients
Oct. 26, 2026

BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients

Indeterminate GlobeNewswire
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
Oct. 26, 2026

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

Indeterminate GlobeNewswire
Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
Oct. 26, 2026

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Persian Gulf Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.